Treatment Options for Metastatic Castration-Sensitive Prostate Cancer (mCSPC): Managing Side Effects


Recorded Webinar

Speaker: Andrew Ruplin, PharmD and Tanya Thomas, DNP, APRN, AGCNS-BC, OCN®

While there are many treatment options available for metastatic castration-sensitive prostate cancer (mCSPC), each comes with the potential for side effects. This webinar will discuss some of the treatments currently available, their side effect profiles, and symptom management strategies.

Access the Facilitator Guide

This activity was developed by ONS through an educational grant from Astellas and Pfizer Inc. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.